Pacific Biosciences Of California Price to Sales Ratio 2012-2025 | PACB
Historical PS ratio values for Pacific Biosciences Of California (PACB) over the last 10 years. The current P/S ratio for Pacific Biosciences Of California as of February 13, 2026 is .
| Pacific Biosciences Of California P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2026-02-13 | 1.71 | 3.28 | |
| 2025-09-30 | 1.28 | $0.52 | 2.45 |
| 2025-06-30 | 1.24 | $0.54 | 2.30 |
| 2025-03-31 | 1.18 | $0.54 | 2.19 |
| 2024-12-31 | 1.83 | $0.56 | 3.28 |
| 2024-09-30 | 1.70 | $0.65 | 2.60 |
| 2024-06-30 | 1.37 | $0.72 | 1.89 |
| 2024-03-31 | 3.75 | $0.78 | 4.79 |
| 2023-12-31 | 9.81 | $0.80 | 12.27 |
| 2023-09-30 | 8.35 | $0.69 | 12.08 |
| 2023-06-30 | 13.30 | $0.62 | 21.58 |
| 2023-03-31 | 11.58 | $0.58 | 19.83 |
| 2022-12-31 | 8.18 | $0.57 | 14.29 |
| 2022-09-30 | 5.81 | $0.63 | 9.26 |
| 2022-06-30 | 4.42 | $0.65 | 6.84 |
| 2022-03-31 | 9.10 | $0.64 | 14.17 |
| 2021-12-31 | 20.46 | $0.64 | 31.89 |
| 2021-09-30 | 25.55 | $0.62 | 41.19 |
| 2021-06-30 | 34.97 | $0.57 | 61.09 |
| 2021-03-31 | 33.31 | $0.53 | 62.96 |
| 2020-12-31 | 25.94 | $0.48 | 54.01 |
| 2020-09-30 | 9.87 | $0.51 | 19.42 |
| 2020-06-30 | 3.45 | $0.54 | 6.42 |
| 2020-03-31 | 3.06 | $0.59 | 5.21 |
| 2019-12-31 | 5.14 | $0.60 | 8.62 |
| 2019-09-30 | 5.16 | $0.56 | 9.26 |
| 2019-06-30 | 6.05 | $0.55 | 11.03 |
| 2019-03-31 | 7.23 | $0.55 | 13.12 |
| 2018-12-31 | 7.40 | $0.60 | 12.35 |
| 2018-09-30 | 5.41 | $0.69 | 7.84 |
| 2018-06-30 | 3.55 | $0.76 | 4.67 |
| 2018-03-31 | 2.05 | $0.80 | 2.56 |
| 2017-12-31 | 2.64 | $0.91 | 2.89 |
| 2017-09-30 | 5.25 | $0.97 | 5.43 |
| 2017-06-30 | 3.56 | $1.04 | 3.44 |
| 2017-03-31 | 5.17 | $1.06 | 4.86 |
| 2016-12-31 | 3.80 | $1.03 | 3.71 |
| 2016-09-30 | 8.96 | $1.22 | 7.36 |
| 2016-06-30 | 7.04 | $1.12 | 6.30 |
| 2016-03-31 | 8.50 | $1.22 | 6.99 |
| 2015-12-31 | 13.13 | $1.22 | 10.72 |
| 2015-09-30 | 3.66 | $0.98 | 3.72 |
| 2015-06-30 | 5.76 | $1.10 | 5.22 |
| 2015-03-31 | 5.84 | $0.93 | 6.27 |
| 2014-12-31 | 7.84 | $0.86 | 9.06 |
| 2014-09-30 | 4.91 | $0.77 | 6.37 |
| 2014-06-30 | 6.18 | $0.59 | 10.43 |
| 2014-03-31 | 5.35 | $0.53 | 10.13 |
| 2013-12-31 | 5.23 | $0.45 | 11.53 |
| 2013-09-30 | 5.52 | $0.41 | 13.35 |
| 2013-06-30 | 2.53 | $0.35 | 7.23 |
| 2013-03-31 | 2.49 | $0.38 | 6.50 |
| 2012-12-31 | 1.70 | $0.47 | 3.63 |
| 2012-09-30 | 1.83 | $0.59 | 3.08 |
| 2012-06-30 | 2.17 | $0.74 | 2.94 |
| 2012-03-31 | 3.42 | $0.81 | 4.25 |
| 2011-12-31 | 2.80 | $0.63 | 4.45 |
| 2011-09-30 | 3.21 | $0.43 | 7.53 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.516B | $0.160B |
| Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time (SMRT) technology. SMRT generates long reads that help in assembling a whole human genome from scratch, without using an existing reference genome as a template. This process is known as de novo assembly. To observe DNA replication process smoothly, PacBio offers the SMRT Cell, Phospholinked nucleotides and The PacBio RS II System. The PacBio RS II System includes the PacBio RS II instrument, consumables and software. PacBio launched its new Sequel system based on SMRT technology. PacBio deferred the gain from the Reverse Termination Fee from Illumina until the date when the associated contingency was resolved. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $189.665B | 22.07 |
| Intuitive Surgical (ISRG) | United States | $172.536B | 66.55 |
| IDEXX Laboratories (IDXX) | United States | $50.254B | 48.15 |
| Edwards Lifesciences (EW) | United States | $44.027B | 29.64 |
| Alcon (ALC) | Switzerland | $39.174B | 26.40 |
| IQVIA Holdings (IQV) | United States | $28.430B | 15.36 |
| Mettler-Toledo (MTD) | United States | $27.662B | 31.81 |
| DexCom (DXCM) | United States | $26.948B | 33.50 |
| STERIS (STE) | Ireland | $24.357B | 24.64 |
| Waters (WAT) | United States | $19.256B | 24.63 |
| Coloplast (CLPBY) | Denmark | $17.511B | 26.79 |
| Hologic (HOLX) | United States | $16.752B | 17.53 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.334B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $14.168B | 11.75 |
| Penumbra (PEN) | United States | $13.288B | 93.47 |
| Globus Medical (GMED) | United States | $11.790B | 24.74 |
| SARTORIUS (SSSGY) | Germany | $7.976B | 46.32 |
| Masimo (MASI) | United States | $6.991B | 22.40 |
| Glaukos (GKOS) | United States | $6.287B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $5.363B | 17.75 |
| Teleflex (TFX) | United States | $4.585B | 7.31 |
| TransMedics (TMDX) | United States | $4.437B | 52.57 |
| LivaNova (LIVN) | United Kingdom | $3.593B | 19.41 |
| Integer Holdings (ITGR) | United States | $3.011B | 14.13 |
| Veracyte (VCYT) | United States | $2.828B | 32.22 |
| Elekta AB (EKTAY) | Sweden | $2.266B | 21.19 |
| Alphatec Holdings (ATEC) | United States | $1.985B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $1.975B | 21.79 |
| UFP Technologies (UFPT) | United States | $1.896B | 25.03 |
| Artivion (AORT) | United States | $1.734B | 58.10 |
| Pulse Biosciences (PLSE) | United States | $1.559B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $1.553B | 0.00 |
| AxoGen (AXGN) | United States | $1.533B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.285B | 0.00 |
| IRadimed (IRMD) | United States | $1.270B | 57.03 |
| OPKO Health (OPK) | United States | $0.944B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.882B | 4.78 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.692B | 13.80 |
| SiBone (SIBN) | United States | $0.665B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.614B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.612B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.591B | 34.35 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.530B | 0.00 |
| NeuroPace (NPCE) | United States | $0.501B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.500B | 13.03 |
| AngioDynamics (ANGO) | United States | $0.452B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.424B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.385B | 0.00 |
| RxSight (RXST) | United States | $0.331B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.329B | 54.76 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Sight Sciences (SGHT) | United States | $0.283B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.281B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.235B | 0.00 |
| 908 Devices (MASS) | United States | $0.235B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.183B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.175B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.173B | 0.00 |
| Inogen (INGN) | United States | $0.156B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.149B | 0.00 |
| LENSAR (LNSR) | United States | $0.146B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.146B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.132B | 0.00 |
| CVRx (CVRX) | United States | $0.130B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.119B | 0.00 |
| Hyperfine (HYPR) | United States | $0.108B | 0.00 |
| Neuronetics (STIM) | United States | $0.097B | 0.00 |
| Solana (HSDT) | United States | $0.091B | 0.00 |
| DarioHealth (DRIO) | United States | $0.079B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| InspireMD (NSPR) | United States | $0.074B | 0.00 |
| Positron (POSC) | United States | $0.067B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.067B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.063B | 0.00 |
| Accuray (ARAY) | United States | $0.062B | 0.00 |
| Spectral AI (MDAI) | United States | $0.048B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.036B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.026B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.021B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.020B | 0.00 | |
| Envoy Medical (COCH) | United States | $0.017B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.013B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.011B | 0.00 |
| NexGel (NXGL) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.006B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ENvue Medical (FEED) | United States | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |